{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:47:15Z","timestamp":1763664435194,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00210-14"],"award-info":[{"award-number":["APQ-00210-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00277-020-04385-9","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T06:02:52Z","timestamp":1609912972000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ADAMTS-13\u2013VWF axis in sickle cell disease patients"],"prefix":"10.1007","volume":"100","author":[{"given":"Val\u00e9ria Sutana","family":"Ladeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Rodrigues","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Mendes","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Gon\u00e7alves Resende","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wander Valadares","family":"de Oliveira J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane","family":"de Oliveira Ren\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna Afonso","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Gon\u00e7alves","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luci Maria Sant\u2019Ana","family":"Dusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9rica Lima","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-3543","authenticated-orcid":false,"given":"Melina","family":"de Barros Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6377-241X","authenticated-orcid":false,"given":"Danyelle Romana Alves","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"4385_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1590\/S1516-84842007000300005","volume":"29","author":"MHDC Ferraz","year":"2007","unstructured":"Ferraz MHDC, Murao M (2007) Diagn\u00f3stico laboratorial da doen\u00e7a falciforme em neonatos e ap\u00f3s o sexto m\u00eas de vida. Rev Bras Hematol Hemoter 29:218\u2013222","journal-title":"Rev Bras Hematol Hemoter"},{"key":"4385_CR2","doi-asserted-by":"crossref","unstructured":"Chakravorty S, Williams TN (2015) Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child BMJ Publishing Group: 100: 48\u201353","DOI":"10.1136\/archdischild-2013-303773"},{"key":"4385_CR3","doi-asserted-by":"crossref","unstructured":"Lim MY, Ataga KI, Key NS (2013) Hemostatic abnormalities in sickle cell disease. Current Opinion in Hematology. p. 472\u20137","DOI":"10.1097\/MOH.0b013e328363442f"},{"key":"4385_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2015.12.003","volume":"30","author":"D Noubouossie","year":"2016","unstructured":"Noubouossie D, Key NS, Ataga KI (2016) Coagulation abnormalities of sickle cell disease: relationship with clinical outcomes and the effect of disease modifying therapies. Blood Rev 30:245\u2013256","journal-title":"Blood Rev"},{"key":"4385_CR5","doi-asserted-by":"crossref","unstructured":"Pakbaz Z, Wun T (2014) Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics. Hematology\/Oncology Clinics of North America. p. 355\u201374","DOI":"10.1016\/j.hoc.2013.11.011"},{"key":"4385_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11239-016-1418-4","volume":"43","author":"A Al-Awadhi","year":"2017","unstructured":"Al-Awadhi A, Adekile A, Marouf R (2017) Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait. J Thromb Thrombolysis Springer New York LLC 43:117\u2013123","journal-title":"J Thromb Thrombolysis"},{"key":"4385_CR7","doi-asserted-by":"crossref","unstructured":"Ataga KI, Moore CG, Hillery CA, Jones S, Whinna HC, Strayhorn D, Sohier C, Hinderliter A, Parise L V., Orringer EP. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica Haematologica; 2008; 93: 20\u20136","DOI":"10.3324\/haematol.11763"},{"key":"4385_CR8","doi-asserted-by":"crossref","unstructured":"Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, Strayhorn D, Hinderliter A, Key NS. Association of coagulation activation with clinical complications in sickle cell disease. PLoS ONE. 2012","DOI":"10.1371\/journal.pone.0029786"},{"key":"4385_CR9","doi-asserted-by":"crossref","unstructured":"Stypulkowski JB, Manfredini V. Altera\u00e7\u00f5es hemost\u00e1ticas em pacientes com doen\u00e7a falciforme. Revista Brasileira de Hematologia e Hemoterapia. 2010. p. 56\u201362","DOI":"10.1590\/S1516-84842010005000001"},{"key":"4385_CR10","doi-asserted-by":"crossref","unstructured":"Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA. Clinical biomarkers in sickle cell disease. Saudi Journal of Biological Sciences. Elsevier; 2015. p. 24\u201331","DOI":"10.1016\/j.sjbs.2014.09.005"},{"key":"4385_CR11","doi-asserted-by":"crossref","unstructured":"Shah N, Thornburg C, Telen MJ, Ortel TL. Characterization of the hypercoagulable state in patients with sickle cell disease. Thromb Res; 2012; 130","DOI":"10.1016\/j.thromres.2012.08.307"},{"key":"4385_CR12","doi-asserted-by":"crossref","unstructured":"Can\u00e7ado RD, Jesus JA. A doen\u00e7a falciforme no Brasil. Rev Bras Hematol Hemoter Elsevier BV; 2007; 29: 204\u20136","DOI":"10.1590\/S1516-84842007000300002"},{"key":"4385_CR13","doi-asserted-by":"crossref","unstructured":"Steinberg MH. Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. TheScientificWorldJournal. Scientific World Journal; 2008. p. 1295\u2013324","DOI":"10.1100\/tsw.2008.157"},{"key":"4385_CR14","doi-asserted-by":"crossref","unstructured":"Noubouossie DCF, L\u00ea PQ, Rozen L, Ziereisen F, Willems D, Demulder A, Ferster A. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment. Eur J Haematol; 2013; 91: 46\u201354","DOI":"10.1111\/ejh.12113"},{"key":"4385_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","volume":"132","author":"J Chen","year":"2018","unstructured":"Chen J, Chung DW (2018) Inflammation, von Willebrand factor, and ADAMTS13. Blood 132:141\u2013147","journal-title":"Blood"},{"key":"4385_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/S1516-84842010005000043","volume":"32","author":"LC Tonaco","year":"2010","unstructured":"Tonaco LC, Rios DRA, Vieira LM, Carvalho MG, Dusse LMS (2010) P\u00farpura trombocitop\u00eanica tromb\u00f3tica: O papel do fator von willebrand e da ADAMTS13. Rev Bras Hematol Hemoter 32:155\u2013161","journal-title":"Rev Bras Hematol Hemoter"},{"key":"4385_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jth.13898","volume":"16","author":"K South","year":"2018","unstructured":"South K, Lane DA (2018) ADAMTS-13 and von Willebrand factor: a dynamic duo. J Thromb Haemost 16:6\u201318","journal-title":"J Thromb Haemost"},{"key":"4385_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood-2018-02-791533","volume":"132","author":"C Masias","year":"2018","unstructured":"Masias C, Cataland SR (2018) The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood 132:903\u2013910","journal-title":"Blood"},{"key":"4385_CR19","doi-asserted-by":"crossref","unstructured":"Zheng XL (2013) Structure-function and regulation of ADAMTS-13 protease. J Thromb Haemost:11\u201323","DOI":"10.1111\/jth.12221"},{"key":"4385_CR20","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1182\/blood-2006-02-002139","volume":"108","author":"D Shang","year":"2006","unstructured":"Shang D, Zheng XW, Niiya M, Zheng XL (2006) Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood 108:2207\u20132215","journal-title":"Blood"},{"key":"4385_CR21","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.1411979112","volume":"111","author":"K South","year":"2014","unstructured":"South K, Luken BM, Crawley JT, Phillips R, Thomas M, Collins RF, Deforche L, Vanhoorelbeke K, Lane DA (2014) Conformational activation of ADAMTS13. National Academy of Sciences 111:18578\u201318583","journal-title":"National Academy of Sciences"},{"key":"4385_CR22","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1182\/blood-2009-07-231597","volume":"114","author":"NA Turner","year":"2009","unstructured":"Turner NA, Nolasco L, Ruggeri ZM, Moake JL (2009) Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood 114:5102\u20135111","journal-title":"Blood"},{"key":"4385_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jth.13922","volume":"16","author":"E Roose","year":"2018","unstructured":"Roose E, Schelpe AS, Joly BS, Peetermans M, Verhamme P, Voorberg J, Greinacher A, Deckmyn H, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K (2018) An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura. J Thromb Haemost Blackwell Publishing Ltd 16:378\u2013388","journal-title":"J Thromb Haemost"},{"key":"4385_CR24","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1182\/blood-2005-05-2029","volume":"106","author":"Z Tao","year":"2005","unstructured":"Tao Z, Peng Y, Nolasco L, Cal S, Lopez-Otin C, Li R, Moake JL, L\u00f3pez JA, Dong JF (2005) Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. Blood 106:4139\u20134145","journal-title":"Blood"},{"key":"4385_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","volume":"106","author":"M Uemura","year":"2005","unstructured":"Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto TA, Mori T, Wanaka A, Fukui H, Fujimura Y (2005) Localization of ADAMTS13 to the stellate cells of human liver. Blood 106:922\u2013924","journal-title":"Blood"},{"key":"4385_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 413:488\u2013494","journal-title":"Nature."},{"key":"4385_CR27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/j.1538-7836.2006.01959.x","volume":"4","author":"N Turner","year":"2006","unstructured":"Turner N, Nolasco L, Tao Z, Dong JF, Moake J (2006) Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 4:1396\u20131404","journal-title":"J Thromb Haemost"},{"key":"4385_CR28","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1111\/j.1538-7836.2005.01561.x","volume":"3","author":"L Liu","year":"2005","unstructured":"Liu L, Choi H, Bernardo A, Bergeron AL, Nolasco L, Ruan C, Moake JL, Dong JF (2005) Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost 3:2536\u20132544","journal-title":"J Thromb Haemost"},{"key":"4385_CR29","unstructured":"Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, Ashida SI, Soejima K, Okada Y, Ikeda Y. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun Academic Press Inc.; 2004; 313: 212\u20136"},{"key":"4385_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/ijlh.12874","volume":"40","author":"LMM Oliveira","year":"2018","unstructured":"Oliveira LMM, Amorim MVA, Corsini CA, Neto CCA, Chaves DG (2018) Standardization and comparison of nonautomated assays to measure the collagen binding activity of von Willebrand factor. Int J Lab Hematol 40:597\u2013603","journal-title":"Int J Lab Hematol"},{"key":"4385_CR31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1160\/TH08-10-0677","volume":"101","author":"Z Zhou","year":"2009","unstructured":"Zhou Z, Han H, Cruz MA, L\u00f3pez JA, Dong J, Guchhait P (2009) Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost 101:1070\u20131077","journal-title":"Thromb Haemost"},{"key":"4385_CR32","doi-asserted-by":"crossref","unstructured":"Jousselme E, Jourdy Y, Rugeri L, N\u00e9grier C, Nougier C. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF. Int J Lab Hematol Blackwell Publishing Ltd; 2018; 40: 77\u201383","DOI":"10.1111\/ijlh.12743"},{"key":"4385_CR33","doi-asserted-by":"crossref","unstructured":"Sonneveld MAH, Franco OH, Ikram MA, Hofman A, Kavousi M, De Maat MPM, Leebeek FWG. Von Willebrand factor, ADAMTS13, and the risk of mortality: the Rotterdam study. Arterioscler Thromb Vasc Biol Lippincott Williams and Wilkins; 2016; 36: 2446\u201351","DOI":"10.1161\/ATVBAHA.116.308225"},{"key":"4385_CR34","doi-asserted-by":"crossref","unstructured":"Denorme F, Kraft P, Pareyn I, Drechsler C, Deckmyn H, Vanhoorelbeke K, Kleinschnitz C, De Meyer SF. Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease. PLoS One Public Library of Science; 2017; 12","DOI":"10.1371\/journal.pone.0179258"},{"key":"4385_CR35","doi-asserted-by":"crossref","unstructured":"Zago MA, Pinto ACS. Fisiopatologia das doen\u00e7as falciformes: Da muta\u00e7\u00e3o gen\u00e9tica \u00e0 insufici\u00eancia de m\u00faltiplos \u00f3rg\u00e3os. Revista Brasileira de Hematologia e Hemoterapia. 2007. p. 207\u201314","DOI":"10.1590\/S1516-84842007000300003"},{"key":"4385_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1590\/S1516-84842007000300009","volume":"29","author":"JAP Braga","year":"2007","unstructured":"Braga JAP (2007) Medidas gerais no tratamento das doen\u00e7as falciformes. Rev Bras Hematol Hemoter 29:233\u2013238","journal-title":"Rev Bras Hematol Hemoter"},{"key":"4385_CR37","unstructured":"Brasil. Minist\u00e9rio Da Sa\u00fade Secretaria De Aten\u00e7\u00e3o \u00c0 Sa\u00fade Secretaria De Ci\u00eancia, Tecnologia E Insumos Estrat\u00e9gicos Portaria Conjunta No. Minist\u00e9rio da Sa\u00fade. 2018. p. 38"},{"key":"4385_CR38","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1160\/TH11-10-0689","volume":"107","author":"GT Gerotziafas","year":"2012","unstructured":"Gerotziafas GT, van Dreden P, Chaari M, Galea V, Khaterchi A, Lionnet F, Stankovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, Girot R, Hatmi M, Elalamy I (2012) The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived micro particles. Thromb Haemost 107:1044\u20131052","journal-title":"Thromb Haemost"},{"key":"4385_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-013-1028-3","volume":"38","author":"M Kasar","year":"2014","unstructured":"Kasar M, Bo\u011fa C, Yeral M, Asma S, Kozanoglu I, Ozdogu H (2014) Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease. J Thromb Thrombolysis Kluwer Academic Publishers 38:167\u2013175","journal-title":"J Thromb Thrombolysis"},{"key":"4385_CR40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3324\/haematol.2012.073619","volume":"98","author":"D N\u00e9bor","year":"2013","unstructured":"N\u00e9bor D, Romana M, Santiago R, Vachiery N, Picot J, Broquere C, Chaar V, Doumdo L, Odi\u00e8vre MH, Benkerrou M, Elion J (2013) Fetal hemoglobin and hydroxycarbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica 98:862\u2013867","journal-title":"Haematologica"},{"key":"4385_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","volume":"142","author":"M Westerman","year":"2008","unstructured":"Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, Eze A, Lawrie A, Purdy G, Mackie I, Porter J (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 142:126\u2013135","journal-title":"Br J Haematol"},{"key":"4385_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000362148","volume":"133","author":"DM Brunetta","year":"2015","unstructured":"Brunetta DM, De Santis GC, Silva-Pinto AC, Oliveira De Oliveira LC, Covas DT (2015) Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia. Acta Haematol S. Karger AG 133:287\u2013294","journal-title":"Acta Haematol"},{"key":"4385_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/08880010390220090","volume":"20","author":"A Koc","year":"2003","unstructured":"Koc A, Gumruk F, Gurgey A (2003) The effect of hydroxyurea on the coagulation system in sickle cell anemia and \u03b2-thalassemia intermedia patients: a preliminary study. Pediatr Hematol Oncol 20:429\u2013434","journal-title":"Pediatr Hematol Oncol"},{"key":"4385_CR44","doi-asserted-by":"crossref","unstructured":"Cannas G, Poutrel S, Thomas X. Hydroxycarbamine: From an old drug used in malignant hemopathies to a current standard in sickle cell disease. Mediterranean Journal of Hematology and Infectious Diseases. Universita Cattolica del Sacro Cuore; 2017","DOI":"10.4084\/mjhid.2017.015"},{"key":"4385_CR45","doi-asserted-by":"crossref","unstructured":"McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol; 2011; 18: 158\u2013165","DOI":"10.1097\/MOH.0b013e32834521dd"},{"key":"4385_CR46","doi-asserted-by":"crossref","unstructured":"McGann PT, Ware RE. Hydroxyurea therapy for sickle cell anemia. Expert Opinion on Drug Safety. Taylor and Francis Ltd; 2015. p. 1749\u201358","DOI":"10.1517\/14740338.2015.1088827"},{"key":"4385_CR47","doi-asserted-by":"crossref","unstructured":"Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood; 2010. p. 5300\u201311","DOI":"10.1182\/blood-2009-04-146852"},{"key":"4385_CR48","doi-asserted-by":"crossref","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. New England Journal of Medicine. Massachussetts Medical Society; 2017. p. 1561\u201373","DOI":"10.1056\/NEJMra1510865"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-04385-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T05:07:11Z","timestamp":1611119231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-04385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4385"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04385-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Research Ethics Committee of the Federal University of S\u00e3o Joao Del-Rei (CAAE: 27639814.2.0000.5545) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}